Visionable Appoints First CCO Following Rapid Growth in 2020

VisionableBritish health technology company Visionable has announced the appointment of David Walker to the newly created position of Chief Commercial Officer (CCO), effective immediately. Visionable redesigns healthcare through a digital collaboration platform which enables clinicians to deliver better patient outcomes.

The expansion of the business’ Executive Leadership team follows Visionable’s rapid growth in 2020, which saw £17 million of investment that the company raised in Series A and Series A1 funding rounds.

Visionable has appointed Walker to capitalise on its existing success. The company’s first CCO, Walker will be responsible for developing and creating new partnerships with international organisations to expand Visionable's presence in thriving markets. He will also be identifying new markets where the company’s technology can make huge differences to current practices and efficiencies, also overseeing the expansion of the team as Visionable grows.

Walker has leadership experience in a range of industries, having held senior commercial roles at Sky Television, Dyson, fintech Neyber, and most recently as CCO of AI based technology company Winnow. His experience in creating compelling propositions from innovative products places him in a unique position to understand and deliver on Visionable's current offering and messaging.

Commenting on his new appointment, David Walker said, "I was drawn to Visionable because of the company’s clear dedication to its mission to make healthcare more equitable and accessible for all and its proposition that is changing healthcare as we know it: creating advanced, efficient systems that deliver better outcomes for both patients and professionals."

"Visionable is at an exciting phase of its development, experiencing exceptional demand, poised to scale up and with patented and unique technology to support its vision. I'm delighted to join the Visionable team and be involved in this next stage of the company's growth."

CEO and co-founder of Visionable, Alan Lowe, said, "David has proved his ability, throughout a stellar career, to boost a company’s market share by selling value rather than price, a principle that is intrinsic to Visionable. I’m delighted to welcome David as CCO to our expanding executive team and look forward to working closely with him as we forge partnerships and enter new markets to improve equity in healthcare and deliver better patient outcomes."

About Visionable

Visionable is a healthcare technology company, established in 2015, that provides a digital collaboration platform for clinicians to deliver better patient care. Designed by founders who have worked within the NHS and who continue to partner closely with NHS clinicians, the platform has been created to develop fit-for-purpose digital care pathways and virtual care consultations. Used by NHS hospitals and Trusts, Visionable has delivered and improved patient flow, facilitated quicker decision making and improved patient experience across multiple care settings and specialities such as stroke. This extends to patient consultations, remote diagnostics, telehealth solutions, multidisciplinary teams, virtual visits, and critical patient services.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...